Tirzepatide, a innovative medication, is sparking considerable interest within the medical community. It operates differently from common diabetes medications, targeting multiple receptors involved in sugar regulation and hunger . Initial research have demonstrated significant efficacy in lowering blood glucose in individuals with adult-onset diabe